Edinburgh-based angel syndicate Archangels leveraged £41.1 million of investment into Scottish scale-ups during 2025, marking a 50% increase on the previous year as it backed a new wave of high-growth tech and life sciences businesses.

The total included £12.8m invested directly by Archangels’ members, alongside £28.4m secured from co-investors such as the Scottish National Investment Bank, Scottish Enterprise and Par Equity.

The year also delivered a successful exit through the sale of wearable tech firm Reactec to Ideagen, contributing to £40m returned to members over the past four years.

Key deals supported included funding rounds for underwater communications specialist CSignum, semiconductor firm Neuranics and dental imaging company Calcivis.